| For: | Nielsen JA, Steephen A, Lewin M. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol 2013; 19(40): 6928-6930 [PMID: 24187471 DOI: 10.3748/wjg.v19.i40.6928] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i40/6928.htm |
| Number | Citing Articles |
| 1 |
Nazeer Ahmed, Ashley Martinelli, Catherine Kiruthi. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2015; 37 doi: 10.1016/bs.seda.2015.08.003
|
| 2 |
Stephan Miehlke, Danila Guagnozzi, Yamile Zabana, Gian E. Tontini, Anne‐Marie Kanstrup Fiehn, Signe Wildt, Johan Bohr, Ole Bonderup, Gerd Bouma, Mauro D'Amato, Peter J. Heiberg Engel, Fernando Fernandez‐Banares, Gilles Macaigne, Henrik Hjortswang, Elisabeth Hultgren‐Hörnquist, Anastasios Koulaouzidis, Jouzas Kupcinskas, Stefania Landolfi, Giovanni Latella, Alfredo Lucendo, Ivan Lyutakov, Ahmed Madisch, Fernando Magro, Wojciech Marlicz, Emese Mihaly, Lars K. Munck, Ann‐Elisabeth Ostvik, Árpád V. Patai, Plamen Penchev, Karolina Skonieczna‐Żydecka, Bas Verhaegh, Andreas Münch. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterology Journal 2021; 9(1) doi: 10.1177/2050640620951905
|
| 3 |
Nan Lan, Bo Shen, Lisi Yuan, Xiuli Liu. Comparison of clinical features, treatment, and outcomes of collagenous sprue, celiac disease, and collagenous colitis. Journal of Gastroenterology and Hepatology 2017; 32(1) doi: 10.1111/jgh.13592
|
| 4 |
R. Estévez-González, Á. Romo Navarro, Á. Sánchez Castaño, M.P. López Castañeyra. 70-year-old woman with chronic diarrhea. Revista Clínica Española (English Edition) 2021; 221(7) doi: 10.1016/j.rceng.2020.12.005
|
| 5 |
Stephen M Lagana, Eric D Braunstein, Carolina Arguelles-Grande, Govind Bhagat, Peter H R Green, Benjamin Lebwohl. Sprue-like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers. Journal of Clinical Pathology 2015; 68(1) doi: 10.1136/jclinpath-2014-202615
|
| 6 |
Kaitlyn Mi, Scarlett Cao, Dawn Adams. Non-celiac Enteropathies. Current Gastroenterology Reports 2025; 27(1) doi: 10.1007/s11894-025-00979-3
|
| 7 |
G. Solano-Iturri, N. García-Jiménez, J.D. Solano-Iturri, S. Blanco-Sampascual. Enteropatía sprue-like asociada a olmesartán: causa emergente de diarrea crónica asociada a fármacos. Revista de Gastroenterología de México 2018; 83(1) doi: 10.1016/j.rgmx.2016.06.006
|
| 8 |
Stephen M. Lagana, Govind Bhagat. Biopsy Diagnosis of Celiac Disease. Gastroenterology Clinics of North America 2019; 48(1) doi: 10.1016/j.gtc.2018.09.003
|
| 9 |
Alexey M. Osadchuk, Nina A. Fadeeva, Nuriya A. Dashkina, Irina D. Loranskaya, Sergey G. Khomeriki. Clinical cases of microscopic colitis: Diagnosis and treatment issues. Case report. Terapevticheskii arkhiv 2023; 95(11) doi: 10.26442/00403660.2023.11.202468
|
| 10 |
Naresh Bhat, N. K. Anupama, Amit Yelsangikar, Kayal Vizhi. Olmesartan-related sprue-like enteropathy. Indian Journal of Gastroenterology 2014; 33(6) doi: 10.1007/s12664-014-0506-7
|
| 11 |
Isabel A. Hujoel, Alberto Rubio-Tapia. Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block. GE Portuguese Journal of Gastroenterology 2016; 23(2) doi: 10.1016/j.jpge.2016.02.005
|
| 12 |
G. Solano-Iturri, N. García-Jiménez, J.D. Solano-Iturri, S. Blanco-Sampascual. Olmesartan-associated sprue-like enteropathy: An emerging cause of drug-induced chronic diarrhea. Revista de Gastroenterología de México (English Edition) 2018; 83(1) doi: 10.1016/j.rgmxen.2017.03.009
|
| 13 |
Yulia A. Dmitrieva, Irina N. Zakharova, Andrey L. Zaplatnikov, Elena R. Radchenko, Elena I. Epifanova, Lala S. Abdurakhmanova, Polina Y. Pokhvashcheva. Collagenous enteritis as a rare cause of exudative enteropathy in a child. Case report. Pediatrics. Consilium Medicum 2024; (2) doi: 10.26442/26586630.2024.2.202925
|
| 14 |
Felicia D. Allard, Edward B. Stelow. Review of Drug-induced Injury in Mucosal Biopsies From the Tubular Gastrointestinal Tract. Advances in Anatomic Pathology 2019; 26(3) doi: 10.1097/PAP.0000000000000230
|
| 15 |
Nina Burbure, Benjamin Lebwohl, Carolina Arguelles-Grande, Peter H.R. Green, Govind Bhagat, Stephen Lagana. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology. Human Pathology 2016; 50 doi: 10.1016/j.humpath.2015.12.001
|
| 16 |
Rachel Hudacko, Lance Siegel. Acute Gastrointestinal Bleeding in Olmesartan-Associated Collagenous Gastroduodenitis: A Potential Endoscopic Complication. Case Reports in Gastrointestinal Medicine 2018; 2018 doi: 10.1155/2018/3295204
|
| 17 |
Adrián Téllez, Martina Pellicé, Arturo Llobell, José César Milisenda. Enteropatía asociada al uso crónico de olmesartán. Medicina Clínica 2015; 144(3) doi: 10.1016/j.medcli.2014.03.031
|
| 18 |
G. Ianiro, S. Bibbò, M. Montalto, R. Ricci, A. Gasbarrini, G. Cammarota. Systematic review: sprue-like enteropathy associated with olmesartan. Alimentary Pharmacology & Therapeutics 2014; 40(1) doi: 10.1111/apt.12780
|
| 19 |
Angela Xue, Mark R Fowler, Jan Silverman, Emily Sturkie, Evan Raff. A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper. Cureus 2023; doi: 10.7759/cureus.41604
|
| 20 |
Adnan Malik, Faisal Inayat, Muhammad Imran Malik, Muhammad Afzal, Muhammad F Azrak. Olmesartan-Induced Spruelike Enteropathy: An Emerging Cause of Small Bowel Injury. Cureus 2020; doi: 10.7759/cureus.9347
|
| 21 |
|
| 22 |
Tom van Gils, Tine van de Donk, Gerd Bouma, Foke van Delft, E Andra Neefjes-Borst, Chris J J Mulder. The first cases of collagenous sprue successfully treated with thioguanine. BMJ Open Gastroenterology 2016; 3(1) doi: 10.1136/bmjgast-2016-000099
|
| 23 |
Dipti M. Karamchandani, Lindsey Westbrook, Christina A. Arnold. Drug-induced digestive tract injury: decoding some invisible offenders. Human Pathology 2023; 132 doi: 10.1016/j.humpath.2022.06.014
|
| 24 |
Carrie Gallivan, Ian Brown. Olmesartan induced enterocolitis. Pathology 2014; 46(4) doi: 10.1097/PAT.0000000000000104
|
| 25 |
Mickael Basson, Myriam Mezzarobba, Alain Weill, Philippe Ricordeau, Hubert Allemand, Francois Alla, Franck Carbonnel. Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study. Gut 2016; 65(10) doi: 10.1136/gutjnl-2015-309690
|
| 26 |
Rifat Mannan, Kevin M. Waters, Elizabeth Montgomery. Practical Gastrointestinal Pathology. 2021; doi: 10.1007/978-3-030-51268-2_11
|
| 27 |
Ole Haagen Nielsen, Lene Buhl Riis, Silvio Danese, Rasmus Dahlin Bojesen, Christoffer Soendergaard. Proximal collagenous gastroenteritides: Clinical management. A systematic review. Annals of Medicine 2014; 46(5) doi: 10.3109/07853890.2014.899102
|
| 28 |
Badr Al-Bawardy, Shannon P. Sheedy, Michelle B. Herberts, Joseph A. Murray, Alberto Rubio-Tapia, Elizabeth Rajan, David H. Bruining, Stephanie L. Hansel, John M. Barlow, Joel G. Fletcher, Jeff L. Fidler. Collagenous sprue cross-sectional imaging: a comparative blinded study. Abdominal Radiology 2017; 42(2) doi: 10.1007/s00261-016-1007-1
|
| 29 |
Neil O'Morain, Eileen Shannon, John McManus, Vanessa Warner, Hilary Leeson, Helen O'Donovan, Brian Egan, Valerie Byrnes. Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten‐free diet. United European Gastroenterology Journal 2021; 9(8) doi: 10.1002/ueg2.12117
|
| 30 |
Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, Stiliano Maimaris, Giovanni Arpa, Federico Biagi, David S. Sanders. Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers. Alimentary Pharmacology & Therapeutics 2024; 59(4) doi: 10.1111/apt.17855
|
| 31 |
A M Popescu, M Dumbrava. Collagenous sprue – a very rare and challenging diagnosis. Endoscopy 2026; 58(S 03) doi: 10.1055/s-0046-1821471
|
| 32 |
|
| 33 |
Natalia Alzueta, Amaya Echeverría, Lorea Sanz, Carmen Fontela, Teresa Acín, Lidia Montenegro, Javier Garjón. Telmisartan-induced sprue-like enteropathy: a case report. European Journal of Hospital Pharmacy 2020; 27(1) doi: 10.1136/ejhpharm-2018-001669
|
| 34 |
Anthony Whitfield, Emi Khoo, Lydi van Driel, Sneha John. Rare cause of small bowel malabsorption. Internal Medicine Journal 2019; 49(9) doi: 10.1111/imj.14420
|
| 35 |
R. Estévez-González, Á. Romo Navarro, Á. Sánchez Castaño, M.P. López Castañeyra. Mujer de 70 años con diarrea crónica. Revista Clínica Española 2021; 221(7) doi: 10.1016/j.rce.2020.12.005
|
| 36 |
Nicola De Bortoli, Claudio Ripellino, Nazarena Cataldo, Santino Marchi. Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings. Expert Opinion on Drug Safety 2017; 16(11) doi: 10.1080/14740338.2017.1376647
|
| 37 |
Lysandra Voltaggio, Dora Lam-Himlin, Berkeley N Limketkai, Aatur D Singhi, Christina A Arnold. Message in a bottle: decoding medication injury patterns in the gastrointestinal tract. Journal of Clinical Pathology 2014; 67(10) doi: 10.1136/jclinpath-2014-202511
|
| 38 |
Eric V. Marietta, Amanda Cartee, Abdul Rishi, Joseph A. Murray. Drug-Induced Enteropathy. Digestive Diseases 2015; 33(2) doi: 10.1159/000370205
|
| 39 |
Francis Essien, Juakiem Wassem, Joshua Tate, Jared Roberts. Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan. Clinical Case Reports 2021; 9(8) doi: 10.1002/ccr3.4645
|
| 40 |
Ruby Greywoode, Eric D. Braunstein, Carolina Arguelles-Grande, Peter H.R. Green, Benjamin Lebwohl. Olmesartan, Other Antihypertensives, and Chronic Diarrhea Among Patients Undergoing Endoscopic Procedures: A Case-Control Study. Mayo Clinic Proceedings 2014; 89(9) doi: 10.1016/j.mayocp.2014.05.012
|
| 41 |
Adrián Téllez, Martina Pellicé, Arturo Llobell, José César Milisenda. Enteropathy associated with chronic use of olmesartan. Medicina Clínica (English Edition) 2015; 144(3) doi: 10.1016/j.medcle.2015.05.002
|
| 42 |
Isabel A. Hujoel, Joseph A. Murray. Refractory Celiac Disease. 2022; doi: 10.1007/978-3-030-90142-4_8
|
| 43 |
Masaya Iwamuro, Seiji Kawano, Motoyuki Otsuka. Drug-induced mucosal alterations observed during esophagogastroduodenoscopy. World Journal of Gastroenterology 2024; 30(16): 2220-2232 doi: 10.3748/wjg.v30.i16.2220
|
| 44 |
Amanda K. Cartee, Joseph A. Murray. Sprue-like Enteropathy Associated with Olmesartan. Current Cardiovascular Risk Reports 2014; 8(12) doi: 10.1007/s12170-014-0420-7
|
| 45 |
Jennifer A Nielsen, James J Weber, Donna J Lager. Diarrhoea and duodenal disease. Gut 2014; 63(11) doi: 10.1136/gutjnl-2014-307924
|
| 46 |
Margot L. Herman, Alberto Rubio-Tapia, Tsung-Teh Wu, Joseph A. Murray. A Case of Severe Sprue-Like Enteropathy Associated With Valsartan. ACG Case Reports Journal 2015; 2(1) doi: 10.14309/crj.2015.15
|
| 47 |
E. V. Marietta, A. M. Nadeau, A. K. Cartee, I. Singh, A. Rishi, R. S. Choung, T.‐T. Wu, A. Rubio‐Tapia, J. A. Murray. Immunopathogenesis of olmesartan‐associated enteropathy. Alimentary Pharmacology & Therapeutics 2015; 42(11-12) doi: 10.1111/apt.13413
|